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Abstract
Background: Decidualization is a prerequisite for successful implantation and the establishment of pregnancy.
Krüppel-like factor 12 (KLF12) is a negative regulator of endometrial decidualization in vitro. We investigated
whether KLF12 was associated with impaired decidualization under conditions of repeated implantation failure (RIF).
Methods: Uterine tissues were collected from a mouse model of early pregnancy and artificial decidualization for
immunohistochemistry, Western blot and real-time PCR analysis. Reporter gene assays, chromatin
immunoprecipitation-PCR and avidin-biotin conjugate DNA precipitation assays were performed to analyze the
transcriptional regulation of forkhead box O1 (FOXO1) by KLF12. Furthermore, the protein levels of KLF12 and
FOXO1 in patients with RIF were analyzed by Western blot and immunohistochemistry.
Results: KLF12 led to defective implantation and decidualization in the mouse uterine model of early pregnancy
and artificial decidualization by directly binding to the FOXO1 promoter region and inhibiting its expression in
human endometrial stromal cells. Elevated KLF12 expression was accompanied by decreased FOXO1 expression in
the endometria of patients with RIF.
Conclusions: As a novel regulator, KLF12 predominantly controls uterine endometrial differentiation during early
pregnancy and leads to implantation failure.
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Background
Stromal decidualization in the endometrium is crucial for
successful embryo implantation and the maintenance of
pregnancy. This process is defined by the mesenchymal-
to-epithelial transformation of endometrial fibroblasts and
stromal cells into secretory epithelioid decidual cells,
which affect endometrial receptivity [1]. In mice and rats,
mechanical or chemical stimulation of the endometrium
is required to induce decidual transformation. In contrast
with what occurs in many species, decidualization of the
human endometrial stroma begins spontaneously during
the late luteal phase of the menstrual cycle, even in the ab-
sence of a conceptus [2]. Regardless of the mechanism of
initiation, endometrial decidualization is maintained in an
embryo-dependent manner. A variety of pregnancy disor-
ders, including infertility, recurrent pregnancy loss (RPL)
[3], implantation failure [4], utero-placental disorders,
endometriosis [5] and pre-eclampsia [6], have been associ-
ated with impaired decidualization.
The steroid hormones estrogen and progesterone, endo-
metrial autocrine and paracrine factors, and miRNAs have
been implicated in decidualization, although how these
molecules coordinate an endometrial response remains un-
clear [7, 8]. In addition to nuclear receptors (e.g., progester-
one receptor (PR)), some transcription factors have been
identified as critical regulators of decidualization, including
homeobox transcription factors [9], CCAAT/enhancer
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binding protein-β (C/EBPβ) [10], and members of the O
subclass of the forkhead family of transcription factors
(FOXOs) [11]. Sun et al. reported that a zinc finger-
containing transcription factor, Krüppel-like factor 5
(KLF5), is expressed dynamically in the luminal epithelium
and stroma throughout peri-implantation. KLF5 regulates
formation and development of the trophectoderm, inner
cell mass, and primitive endoderm, and KLF5−/− mice dis-
play embryonic lethality due to developmental defects in
the preimplantation embryo. Conditional deletion of KLF5
in the uterus compromises implantation and decidualiza-
tion [12]. To date, many KLFs, such as KLF12, have been
found to participate in steroid hormone signaling and to
exhibit pleiotropic actions in uterine endometrial cells [13–
15]. KLF12 has been shown to bind to the promoter re-
gions of target genes and represses their expression through
an N-terminal PVDLS sequence (Pro-Xaa-Asp-Leu-Ser)
that promotes physical interaction with CtBP co-repressors
[16]. We have previously demonstrated that KLF12 is
expressed in the glandular epithelium (GE) and stromal
cells of secretory phase endometrial tissue and that it nega-
tively regulates endometrial decidualization and marker
gene transcription [14].
In this study, we showed that KLF12 impaired embryo
implantation and endometrial decidualization in mice
and that it regulated FOXO1 expression by binding to a
CAGTGGG element within the FOXO1 promoter.
Moreover, KLF12 was aberrantly expressed in midsecre-




ICR mice were purchased from the Laboratory Animal
Center of Yangzhou University (Yangzhou, China). All
animals were bred at the Laboratory Animal Center of
Nanjing Drum Tower Hospital (Nanjing, China). All
studies were approved by the Institutional Animal Care
and Use Committee of Nanjing Drum Tower Hospital
(SYXK 2009–0017).
Females (six weeks old) were mated with fertile males,
and the morning on which a vaginal plug was observed
was designated as day 0.5 of pregnancy. Twenty microli-
ters (2 × 108 TU/side) of Ad-LacZ or Ad-Flag-KLF12
adenovirus (packaged, amplified and purified as previously
reported [14]) was injected into the bilateral uterine horns
of the mice in the morning on 1.5 days post-coitus (dpc).
Then, the mated mice were intravenously injected with
Chicago Sky Blue 6B (Sigma, St. Louis, MO, USA) in the
afternoon on 4.5 dpc to evaluate the state of implantation
(Fig. 1a).
Artificial decidualization was performed as described
previously [17]. Briefly, six-week-old mice were sub-
jected to bilateral ovariectomy and treated with 20 μL of
Ad-Flag-KLF12 or Ad-LacZ via injection into the bilat-
eral uterine horns (2 × 108 TU/side). Ten days later, the
mice received intravenous injection of 20 μL adenovirus
(2 × 108 TU/mouse). After two days of rest, the mice
were treated with a regimen of E2 and P4 as per the
standard protocol and injected with sesame oil into the
uterine horns as a decidualization stimulus (Fig. 2a).
Endometrial sampling and cell culture
All endometrial samples were obtained via endometrial
biopsy between days 19 and 23 of the menstrual cycle
from 29 patients who exhibited regular menstrual cycles
(28–31 days) and who were not taking any oral contra-
ceptives. The demographic details of the patients are
summarized in Table 1. RIF was defined as the failure to
achieve pregnancy following a minimum of three fresh
or frozen cycles, during which at least four good-quality
embryos were transferred to the uterus [18]. The sub-
jects in the control group had undergone no less than
one successful cycle and delivery. This study was ap-
proved by the Institutional Review Board of Nanjing
Drum Tower Hospital.
Human endometrial stromal cells (hESCs) were iso-
lated and cultured as described previously, and the pur-
ity of the cultured stromal cells was determined by cell
immunohistochemistry, as shown in Additional file 1:
Figure S1. Decidualization was induced according to a
previously published protocol [19, 20].
Western blotting
Proteins were prepared as previously described [19], and
the protein content was measured using the Bradford
assay (Bio-Rad Laboratories, Hercules, CA, USA). Equal
amounts (20 μg) of protein were separated by SDS-
PAGE, and immunoblotting was performed with primary
antibodies against FOXO1 (Cell Signaling Technology,
Danvers, MA, USA, 1:1000), KLF12 (Santa Cruz Bio-
technology, CA, USA, 1:2000) or GAPDH (Bioworld
Technology, MN, USA, 1:10000), followed by incubation
with a horseradish peroxidase (HRP)-conjugated second-
ary antibody and Flag-HRP (Sigma, 1:5000). The bands
were detected using an enhanced chemiluminescence kit
(Amersham Biosciences Corp., Piscataway, NJ, USA),
and densitometric analysis of each band was performed
with Quantity-one (Bio-Rad) software.
Quantitative reverse transcription real-time PCR (qRT-PCR)
Total RNA was extracted from primary hESCs and from
the mouse uterine and human endometrial samples. RNA
was reverse-transcribed and subjected to qRT-PCR ana-
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TCGCCCTTATCCTTGAAGT-3′; hKLF12, sense 5′-CC
TTTCCATAGCCAGAGCAG-3′, antisense 5′-TTGCA
TCCCTCAAAATCACA-3′; hFOXO1, sense 5′-TCAT
GTCAACCTATGGCAG-3′, antisense 5′-CATGGTGCT-
TACCGTGTG-3′; m18S rRNA, sense 5′-CGGACATC-
TAAGGGCATCAC-3′, antisense 5′-ATGGCCGTTCT
TAGTTGGTG-3′; and h18S rRNA, sense 5′-CGGCTAC-
CACATCCAAGGAA-3′, antisense 5′-CTGGAATTACC
GCGGCT-3′. The qRT-PCR data were analyzed using the
2-ΔΔCT method, with 18S rRNA as an internal control.
Immunostaining
After the samples were dewaxed, endogenous peroxidase
activity was blocked using freshly prepared phosphate-
buffered saline (PBS) containing 0.3 % hydrogen perox-
ide for 15 min. Antigen retrieval was conducted by auto-
claving the samples at 121 °C for 15 min in the presence
of EDTA (pH 9.0). The sections were washed with PBS
and then incubated with antibodies against KLF12
(1:600 dilution, Santa Cruz Biotechnology) and FOXO1
(1:100 dilution, Cell Signaling Technology) overnight at
4 °C in a humidified chamber. Afterward, the sections
were rinsed with PBS and incubated with an HRP-
conjugated goat anti-rabbit secondary antibody at 37 °C
for 30 min. HRP activity was detected using diamino-
benzidine (Invitrogen, Carlsbad, CA, USA), and the sec-
tions were counterstained with hematoxylin. Nonspecific
rabbit serum was used as a negative control, and mouse
kidney (KLF12) and human breast carcinoma tissues
(FOXO1) were employed as positive controls.
Measurement of KLF12 and FOXO1 protein expression
in the endometrium samples was performed using Image-
Pro Plus System 6.0 (Media Cybernetics, Inc., Silver
Spring, MD, USA) in a blinded fashion, without know-
ledge of the tissue source. Quantitative analysis was per-
formed according to the software’s instructions. The
representative objective protein staining intensity (indicat-
ing the relative expression level) was determined accord-
ing to the mean and integrated optical density (IOD) of
the digital image (×400). Signal density data for the tissue
areas were obtained from five randomly selected fields of
view and subjected to statistical analysis.
Fig. 1 Increased KLF12 expression was associated with impaired implantation in vivo. a The protocol for detecting the effect of KLF12 on embryo
implantation. For specific details, refer to the Methods section (Animals and treatments). b The number of implantation sites (ISs) in the afternoon
on 4.5 dpc in mice infected with adenovirus. c The distinctive banding pattern of a uterine horn stained with Chicago Sky Blue 6B on 4.5 dpc is
indicative of an IS in mice treated with Ad-LacZ (top) and Ad-Flag-KLF12 (bottom). The arrows indicate the locations of the ISs. d A representative
Western blot of Flag-tag protein in the uteri of the Ad-LacZ-treated (lanes 1–4) and Ad-Flag-KLF12-treated (lanes 5–8) mice. GAPDH was used as a
loading control
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Plasmid construction and reporter gene assays
The wild-type FOXO1 promoter sequence, which spans
from −3050 to −2051 bp relative to the transcription
start site (Promoter ID: 11424), was amplified by PCR
from hESC genomic DNA using the following primers:
5′-GGCCGGTACCTTACAGGATATTTATAATTTT-3′
and 5′-AGAAAAGCTTGCCTTGCCTTCATTTCTAT
TC-3′. The PCR product was cloned into a pGL3-basic
luciferase reporter plasmid (Promega, USA).
Preconfluent (70 %) hESCs in 12-well plates were in-
fected with Ad-Flag-KLF12 for 8 h and then transfected
with 0.6 μg FOXO1-Luc plasmid/well using Lipofecta-
mine 2000 (Life Technologies, USA). After 6 h, the cul-
ture medium was changed to DMEM-F12 (Invitrogen,
Carlsbad, CA) with or without 8-Br-cAMP and medrox-
yprogesterone acetate (MPA). The cells were incubated
for an additional 48 h and then harvested for prepar-
ation of cell extracts. Luciferase activity was measured
with a Luciferase Assay System (Promega, Madison,
USA), in which Renilla luciferase plasmids were cotrans-
fected as controls to standardize the transcription effi-
ciency. These assays were performed using a Centro XS3
LB 960 luminometer (Berthold Technologies, BW,
Germany) according to the manufacturer’s protocol.
Chromatin immunoprecipitation (ChIP)-PCR
Purified DNA fragments were extracted from hESCs
and used as templates for PCR and real-time PCR as
described previously [14]. A negative control primer set
targeting a sequence distal (−7672 to −7473 bp) to the
putative binding site was chosen to monitor binding
specificity, with the following sequences: 5′-ACCTGC
Fig. 2 KLF12 overexpression affected decidualization in a mouse model of artificial decidualization. a Experimental scheme. Mice were ovariectomized,
treated with adenovirus, subjected to an E2/P4 regimen to elicit the estrous cycle, and injected with oil as a decidualization stimulus. The uteri were
collected at 5 days after stimulation. b Representative uteri after artificial induction of decidualization in the mice. S and US denote the stimulated and
unstimulated uterine horns, respectively. c The fold changes in the uterine weights of stimulated horns compared with those of unstimulated horns
indicates the extent of decidualization in female mice injected with control Ad-LacZ (n = 6) or Ad-Flag-KLF12 (n = 6) on day 5 after stimulation.
**P < 0.01. d After artificial induction of decidualization, mouse uterine sections were stained with hematoxylin and eosin. myo, myometrium; s, stroma;
le, luminal epithelium; and ge, glandular epithelium. Bar = 500 μm. e mRNA expression level of dPRP during in vivo decidualization was measured by
real-time PCR in the Ad-Flag-KLF12-treated mice (n = 6). *P < 0.05 compared with the Ad-LacZ-treated mice (n = 6). f The FOXO1 mRNA level was
measured by real-time PCR in the Ad-Flag-KLF12-treated (n = 18) and Ad-LacZ-treated mice (n = 14) after 5 days of oil infusion. *P < 0.05
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TGACCCAGTGACTC-3′ and 5′-AGGCTGAGGCAG-
GAGAATG-3′ (−2766 to −2568 bp). The fold enrich-
ment was calculated as the 2-ΔΔCT value and is
presented relative to LacZ (after normalization to the
input). Annealing was performed at 57 °C, and the PCR
products were electrophoresed on 2 % agarose gels and
visualized by GoldView staining.
Avidin-biotin conjugate DNA precipitation (ABCD) assay
Double-stranded oligonucleotides were designed based
on the FOXO1 promoter sequence (−2637 to −2601 bp).
The 5′-end of the sense strand was biotinylated, and a
mutation was introduced (CAGTGGG to CACAAAG)
to remove the specific binding site for KLF12. The fol-
lowing primers were designed: human FOXO1 wild-
type: 5′-biotin–TCAGGCTGGAGTGCAGTGGGGC-
GATCTTGGCTCCGC-3′; human FOXO1 wild-type re-
verse: 5′–GCGGAGCCAAGATCGCCCCACTGCACTC
CAGCCTGA-3′; and human FOXO1 mutant: 5′-biotin–
TCAGGCTGGAGTGCACAAAGGCGATCTTGGCTCC
GC-3′. hESCs were infected with Ad-LacZ and Ad-Flag-
KLF12 (25 MOI) for 48 h and then incubated with 8-Br-
cAMP and MPA for an additional 48 h. Cell extracts were
harvested and lysed in RIPA buffer. Each double-stranded
DNA sample (500 pmol) was incubated with 500 μg of cell
extract at 4 °C for 2–4 h, and the protein complexes were
pulled down using streptavidin agarose beads (Sigma) in
binding buffer (10 mM Tris, pH 8.0; 150 mM NaCl; 0.5 %
Triton X-100; 0.5 mM DTT; 0.5 mM EDTA; 10 %
glycerol; and 20 μg/mL poly [dI–dC]) containing a
protease inhibitor cocktail. The proteins were eluted,
separated by SDS–PAGE, and then probed with an
anti-Flag-HRP antibody.
Statistical analysis
Unless stated otherwise, the numerical data are pre-
sented as the mean ± SD of at least three independent
experiments. Student’s t-test was used to determine the
statistical significance between two groups. ANOVA
with Bonferroni’s correction was employed for multiple
comparisons. Pearson correlation analysis was used to
assess the relationship between FOXO1 and KLF12. Dif-
ferences at P < 0.05 were considered significant.
Results
KLF12 overexpression in the uterus decreased the
embryo implantation rate
Mouse embryo implantation occurs at midnight on 3.5
dpc, as determined based on preimplantation ovarian
steroid profiles [21]. The uterine lumens of ICR mice
were injected with a KLF12-expressing adenovirus (Ad-
Flag-KLF12) or Ad-LacZ on 1.5 dpc (Fig. 1a), and the
implantation status was then examined on 4.5 dpc to de-
termine whether KLF12 was a critical regulator of em-
bryo implantation. Adenovirus-mediated overexpression
of KLF12 markedly increased Flag-KLF12 fusion protein
expression (Fig. 1d). The KLF12-overexpressing mice
had fewer implantation sites (6.18 ± 1.03, n = 11) com-
pared with the Ad-LacZ group (10.27 ± 0.78, n = 11)
(Fig. 1b and c), suggesting that KLF12 blocked embry-
onic implantation.
Increased KLF12 expression in the mouse uterus
repressed uterine decidualization
In a previous study, we demonstrated that KLF12 is a
novel negative regulator of the decidual reaction and that
KLF12 overexpression in hESCs significantly represses
their morphological and biochemical transformation [14].
Based on the observations shown in Fig. 1, we hypothe-
sized that impaired decidualization may cause KLF12-
induced implantation failure; thus, we investigated decid-
ualization in the hormone-primed uteri of ovariectomized
mice treated with a well-established regimen of E2 and P4
(Fig. 2a). As expected, morphological analysis of Ad-LacZ
control mice revealed thicker uterine horns, indicating the
presence of pronounced deciduoma within 5 days after
artificial stimulation (Fig. 2b, left). In contrast, the uteri of
KLF12-overexpressing mice contained thinner and fewer
pseudopregnant sacs under identical conditions (Fig. 2b,
right). As shown in Fig. 2c, the fold changes in the uterine
weights of oil-stimulated horns compared with those of
control horns indicated that the extent of decidualization
was markedly reduced in the KLF12-overexpressing fe-
males. Morphometric analysis of uterine tissue sections
further demonstrated that the stimulated Ad-LacZ horns
were packed with decidual cells, while the KLF12-
overexpressing horns contained a markedly reduced num-
ber of decidual cells (Fig. 2d). Consistent with these re-
sults, the mRNA expression of dPRP, which is a marker of
mouse decidualization [22], was significantly reduced by
almost 50-fold in the uteri of the KLF12-overexpressing
mice (Fig. 2e). Accordingly, increased uterine KLF12 ex-
pression was associated with severe impairment of decid-
ualization. Additionally, FOXO1 mRNA was highly
expressed in the control uteri but was down-regulated
Table 1 Demographic details of the participants in the study of
endometrial KLF12 expression
Fertile FER (n = 14) RPL (n = 15) P
Age (years) 29.5 ± 3.8 32.1 ± 4.3 ns
Body mass index (kg/m2) 20.5 ± 2.6 22.2 ± 5.9 ns
P4 on hCG day (pg/mL) 9.7 ± 3.5 9.3 ± 3.2 ns
Endometrial thickness (mm) 10.2 ± 1.1 10.0 ± 1.8 ns
No. of transferred embryos 2 ± 0 6.5 ± 2.6 s
The data are presented as the mean ± SD unless otherwise indicated. A P < 0.05
was considered significant
P4 Serum progesterone concentration
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(reduced by >30 %) in the uteri from the KLF12-
overexpressing mice (Fig. 2f).
Elevated KLF12 level led to a decrease in FOXO1
expression
To better understand the mechanism by which FOXO1
expression is regulated, we examined its expression fol-
lowing KLF12 up-regulation in hESCs in vitro. As shown
in Fig. 3a and b, infection of hESCs with Ad-Flag-KLF12
(MOI = 25 and 50) for 48 h markedly increased KLF12
mRNA expression (by greater than 110-fold and 200-
fold, respectively). Importantly, KLF12 overexpression in
hESCs resulted in significant dose-dependent decreases
in FOXO1 mRNA (Fig. 3c) and protein (Fig. 3d) expres-
sion in response to 8-Br-cAMP and MPA.
KLF12 directly repressed FOXO1 transcription
We identified a conserved KLF12 binding element
(CAGTGGG) within the FOXO1 core promoter region
similar to a human FOXO1 promoter sequence depos-
ited in transcriptional regulatory element database (Pro-
moter ID: 11424, Fig. 4a). Exogenous hormone-induced
decidual transformation increased FOXO1A promoter
activity, as evidenced by luciferase reporter assays, and
this increase was repressed by KLF12 overexpression
(Fig. 4b). Next, ChIP-PCR assays showed that KLF12
bound to the FOXO1 promoter region (−2637 to
−2601 bp), which contains the conserved CAGTGGG
element; however, no PCR product was obtained from
the negative control region (−7672 to −7473 bp; Fig. 4c,
top). Quantitative ChIP revealed that the primers were
effectively (greater than 35-fold) amplified from Flag-
KLF12 protein immunoprecipitates but not from LacZ
control immunoprecipitates (Fig. 4c, bottom). Moreover,
Flag-tagged KLF12 protein strongly bound to the
FOXO1 promoter containing the CAGTGGG sequence
but not to the mutated probe (Fig. 4d). These data indi-
cate that FOXO1 is a novel target gene of KLF12.
KLF12 and FOXO1 expression was aberrant in the
endometria of patients with RIF
Because the decidual response of hESCs is disrupted in
patients with RIF [23], we further assessed the expres-
sion of KLF12 and FOXO1 in midsecretory endometrial
samples from women with RIF (Table 1). The endomet-
rial KLF12 transcript and protein levels were higher
(greater than 2-fold) in women with RIF compared with
those in fertile controls (Fig. 5a, c and d). Conversely,
expression of FOXO1 was, as expected, significantly re-
duced by 50 % in the women with RIF compared with
that in the fertile controls (Fig. 5b, c and e). The protein
level of FOXO1 was moderately negatively correlated
with that of KLF12 (r = −0.4272395, P = 0.04202). Immu-
nohistochemical analysis revealed that the KLF12 and
FOXO1 protein levels were higher and lower, respect-
ively, in the endometria of patients with RIF compared
with those in the endometria of the fertile controls, par-
ticularly in the stromal compartment (Fig. 5g). We quan-
tified the KLF12 and FOXO1 expression densities in the
endometrium using Image-Pro Plus System 6.0 image
Fig. 3 Elevated KLF12 level led to decreased FOXO1 expression. hESCs were infected with adenovirus expressing either LacZ or KLF12 for 48 h at
the indicated MOI. The KLF12 transcript copy number (a) and its protein expression (b) were determined by real-time PCR and Western blotting
(n = 3). ***P < 0.001 compared with Ad-LacZ alone. hESCs were infected with Ad-LacZ or Ad-Flag-KLF12 at the indicated MOI for 48 h and were
then treated with 8-Br-cAMP and MPA for another 2 days; subsequently, FOXO1 mRNA (c) and protein (d) levels were measured by real-time PCR
and Western blotting, respectively (n = 3). *P < 0.05; **P < 0.01; and ***P < 0.001
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analysis software (Table 2). The IOD of KLF12 for the
fertile controls was 232,246 ± 59,354, while that for the
patients with RIF was 357,937 ± 86,246; in addition, the
mean KLF12 expression density of the patients with RIF
(0.38 ± 0.05) was higher than that of the controls (0.31 ±
0.06). The results also showed that the IOD of FOXO1
for the normal controls (609,115 ± 198,330) was signifi-
cantly higher than that for the patients with RIF
(285,440 ± 117,645). The mean densities for the fertile
and RIF individuals were 0.34 ± 0.08 and 0.27 ± 0.05, re-
spectively. The results of IHC assay shown in Fig. 5g
demonstrate that FOXO1-immunopositive epithelial
cells could still be detected in the patients with RIF. We
further calculated the level of FOXO1 expression in GE
cells. The IOD was 178,465 ± 88,230 (FER, fertile con-
trols) vs. 271,035 ± 119,150 (RIF), and the mean density
was 0.23 ± 0.06 (FER) vs. 0.20 ± 0.04 (RIF) (Table 3). In
GE cells, the IOD of KLF12 for the RIF group was
higher than that for the normal group. These results
suggested that increased KLF12 expression in the
stromal compartment, together with decreased FOXO1
expression, contributed to the impaired decidualization
observed in the women with RIF.
Discussion
This study has verified the important role of KLF12 in the
induced decidualization in mice and is the first report of a
putative molecular mechanism for the transcriptional re-
pression of FOXO1 in hESCs. KLF12 belongs to the zinc
finger-containing transcription factor family, which con-
tains key mediators of endocrine/metabolic processes that
play emerging key roles in human reproductive and uter-
ine diseases [15, 24]. For example, KLF11 is highly
expressed in human urogenital tissues, and aberrant
KLF11 expression has been linked to the pathogeneses of
common uterine diseases, such as endometriosis and leio-
myoma [25, 26]. Moreover, loss of coregulation between
KLF9 and PR may underlie the pathogenesis of endome-
triosis [27]. Furthermore, KLF9 deficiency in the uterus
has been shown to promote the establishment of ectopic
Fig. 4 KLF12 mediated the transcriptional repression of FOXO1. a Schematic of the location of the KLF12 binding site in the FOXO1 promoter. b
hESCs were infected with the indicated adenoviruses for 8 h, transfected with FOXO1-LUC (600 ng/well), and treated with 8-Br-cAMP and MPA. After
48 h, luciferase assays were performed, and the data were plotted after normalization to Renilla luciferase activity (n = 3). **P < 0.01 and ***P < 0.001
compared with Ad-LacZ without 8-Br-cAMP or MPA; ###P < 0.001 compared with Ad-LacZ with 8-Br-cAMP and MPA. c ChIP-PCR amplification using
primers against the human FOXO1 promoter region (top). PCR products were separated by agarose gel electrophoresis. Quantitative ChIP analysis was
performed by real-time PCR. The results are shown as the fold enrichment over LacZ (after normalization to the input, bottom). Input (non-precipitated)
chromatin was utilized as a positive control for these analyses. *P < 0.05. d ABCD assays were performed using biotinylated or non-biotinylated
(competitor) double-stranded FOXO1 wild-type (WT) and mutant (MUT) oligonucleotides with whole-cell extracts from hESCs
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lesions in a mouse model of endometriosis [28]. Finally,
KLF13-null lesions contribute to defective steroid hor-
mone receptor signaling in the pathology of endometriosis
[29], and KLF15 negatively regulates E2-induced epithelial
cell proliferation, which is associated with endometriosis
and endometrial cancer [30]. All of these reproductive dis-
eases in which KLFs have been implicated are associated
with impaired decidualization. Similarly, in this study,
Fig. 5 Detection of KLF12 and FOXO1 expression in patients with RIF. The KLF12 (a) and FOXO1 (b) transcript levels in the uteri of fertile (n = 11)
and RIF (n = 12) patients were quantified by real-time PCR and were then normalized to control 18S gene expression. The data are presented with
respect to the fertile group (expression was set to 1). *P < 0.05 and ***P < 0.001 compared with the fertile group. FER, normal fertility women.
c The difference in protein expression in endometrial samples was assessed by Western blotting using antibodies specific to KLF12 and FOXO1.
Total KLF12 (d) and FOXO1 (e) protein levels were normalized to GAPDH expression, and the data for all of the endometrial samples are shown
in the scatter plots. f Correlation between KLF12 and FOXO1 protein expression (n = 23, P < 0.05). g Immunohistochemical analysis using KLF12
and FOXO1 antibodies. Endometrial tissue samples from fertile women and those with RIF are shown at 200× (left panel) and 400× (right panel)
magnification. The negative control (NC) is nonspecific rabbit serum, and the positive controls are mouse kidney tissue (KLF12) and human breast
carcinoma tissue (FOXO1), respectively. Brown represents positive staining (arrows). Scale bar, 100 μm (left panel) and 50 μm (right panel)
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increased KLF12 expression led to a severe reduction in
endometrial decidualization and blockage of embryo im-
plantation in the endometrium.
KLF12 (AP-2rep) was first identified based on its abil-
ity to bind to and down-regulate an important transcrip-
tion factor, AP2α [31]. Shen et al. found that PRL is a
target gene of KLF12, which directly binds to the
CAGTGGG sequence in the PRL promoter [14]. In the
present study, we similarly identified a novel transla-
tional target of KLF12 in endometrial biology. FOXO1 is
essential for female reproduction and is markedly in-
duced upon decidualization by both the PKA/cAMP
pathway and ligand-activated nuclear PR [32]. FOXO1
physically associates with HOXA10 or PR to modulate
the expression of decidua-specific genes, such as insulin-
like growth factor-binding protein 1 (IGFBP1) [33, 34].
Furthermore, KLF12 not only transcriptionally represses
PRL expression but also reduces the IGFBP1 protein
level during decidualization; however, the mechanism by
which this regulation occurs remains unclear [14]. The
KLF12-mediated repression of FOXO1 expression is po-
tentially the primary cause of impaired decidualization
and subsequent implantation failure. Because FOXO1
directly regulates IGFBP1 but KLF12 does not, the
mechanism underlying the KLF12-mediated inhibition of
IGFBP1 expression via FOXO1 during decidualization
must be further addressed.
Although assisted reproductive technologies have
markedly reduced the incidence of infertility, 45–60 % of
patients undergoing assisted reproduction do not experi-
ence a live birth after 3 treatment cycles [35]. Endomet-
rial receptivity is responsible for RIF in approximately
two-thirds of affected women [36], and stromal decidua-
lization is considered to be important for endometrial
receptivity [4].
As suggested by immunohistochemical analysis of the
endometrium of women with RIF, KLF12 expression is
elevated in stromal cells as well as in the GE. Interac-
tions between the blastocyst and epithelia and those be-
tween epithelial cells and stromal cells are vital to
successful implantation [37, 38]. Paracrine signals from
the blastocyst result in the production of various hor-
mones and cytokines (e.g., chorionic gonadotropin and
interleukin-1) that facilitate attachment and mainten-
ance of pregnancy [39, 40]. After blastocyst attachment,
luminal epithelial cells transmit signals to mediate the
proliferation and differentiation of the endometrium and
to elicit changes in vascular permeability and embryo
migration across the epithelium [41, 42]. The GE, an-
other part of the endometrial epithelium, is embedded
within the stromal bed. Gland-derived signaling influ-
ences stromal function in a paracrine manner [43]. Many
products secreted from the GE, such as leukemia inhibi-
tory factor, appear to support nascent embryos and nor-
mal stromal decidualization during implantation [44, 45].
Aberrant KLF12 expression in the GE may interfere with
crosstalk between the epithelium and stroma, causing
hESC decidualization defects. Furthermore, as an anti-
inflammatory regulator, KLF12 is down-regulated in pa-
tients with aneurysm [46], and decidualization and em-
bryo implantation are usually considered to involve
proinflammatory responses. The higher epithelial KLF12
expression observed during implantation in women with
RIF indicates that the product of this gene may influence
the immuno-inflammatory reaction in the uterine epithe-
lium. Interestingly, in our study, the mean density of
FOXO1 in the GE of the control group was slightly higher
than that in the GE of the RIF group, while the IOD was
weaker in the control group than that in the RIF group.
These differences were associated with a significant
change in the number of GE cells, as well as slightly al-
tered KLF12 expression in these cells. On the other hand,
FOXO1 is required for programmed apoptosis of the epi-
thelium and for safeguarding endometrial homeostasis
during the reproductive phase [11]. Additionally, FOXO1
may be regulated by factors other than KLF12, such as
miRNAs, in endometrial epithelial cells [47].
KLF12 is involved in defective decidualization in pa-
tients with RIF; however, the mechanism by which it is
up-regulated remains unclear. Compromised P4 signal-
ing might be responsible for the abnormal endometrial
Table 2 The means and integrated optical densities of KLF12
and FOXO1 expression in endometrial tissue
Fertile FER (n = 6) RPL (n = 6) P
Mean density of KLF12
expression
0.31 ± 0.006 0.38 ± 0.05 <0.0001





Mean density of FOXO1
expression
0.34 ± 0.08 0.27 ± 0.05 0.0403





The data are presented as the mean ± SD. A P < 0.05 was considered
significant, vs. normal fertility women
Table 3 The area and integrated optical density of FOXO1
expression in GE of endometrium
Fertile FER (n = 6) RPL (n = 6) P
Mean density of KLF12
expression
0.12 ± 0.04 0.15 ± 0.05 0.0282





Mean density of FOXO1
expression
0.23 ± 0.06 0.20 ± 0.04 0.0012





The data are presented as the mean ± SD. A P < 0.05 was considered
significant, vs. normal fertility women
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gene expression observed in women with RIF. Thus, the
outcomes of RIF may be ascribed to abnormal P4-
sensitive maternal signaling rather than to the amount
of progesterone, given the similar levels of secreted pro-
gesterone in the patients and controls observed in this
study. MPA is a synthetic progesterone that interacts
with PR to promote differentiation of the uterine endo-
metrium, and in our study, MPA repressed KLF12 ex-
pression in hESCs in a time-dependent manner (data
not shown). Rubel et al. reported that many members of
the KLF family, such as KLFs 3, 4, 7, and 12, are candi-
date mediators of PR function in P4-responsive target
tissues [48]. Therefore, KLF12, a potential P4-regulated
gene, may be up-regulated by compromised P4 signaling
in the endometria of patients with RIF.
This study constitutes the first functional analysis of
the role of KLF12 in endometrial decidualization and
embryo implantation in vivo. To prevent traumatic
adenovirus infection of the uterine horns, a mouse uter-
ine model with a conditional KLF12 knock-in will be
employed in future studies to unravel the physiological
role and mechanism of action of KLF12 in pregnancy.
Conclusions
Taken together, our results indicate that KLF12, by nega-
tively regulating FOXO1 expression, contributes to im-
proper stromal decidualization and reduced embryo
implantation. These findings may inspire the develop-
ment of new therapeutic regimens for patients with RIF
and disrupted decidualization.
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